Abstract:OBJECTIVE: LncRNA HULC has been proved to have important functions in the pathogenesis of several types of cancers. While its involvement in non-small cell lung cancer (NSCLC), which is one of the most common malignancies, still hasn't been reported to date. Therefore, we aimed to investigate the role of HULC in NSCLC and to explore the possible mechanisms. PATIENTS AND METHODS: Tumor tissues and adjacent healthy tissues were collected from NSCLC patients, and blood samples were collected from both NSCLC patients and healthy controls. Expression of HULU in those tissues was detected by qRT-PCR. All patients were followed up for 5 years. Diagnostic and prognostic values of serum HULU for NSCLC were investigated by ROC curve analysis and survival curve analysis, respectively. HULC overexpression NSCLC cell lines were established and its effects on cell proliferation as well as apoptosis were investigated by CCK-8 assay and MTT assay, respectively. Effects of HULC overexpression on sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway were investigated by Western blot. Results: HULC expression level was increased in tumor tissues compared with adjacent healthy tissues in most patients. Serum level of HULC was higher in cancer patients than that in healthy control. Serum level of HULC was increased with the increased stage of primary tumor (T stage). Serum HULC can be used to accurately predict NSCLC and its prognosis. HULC overexpression promoted tumor cell proliferation, but inhibited cell apoptosis. HULC overexpression also increased expression level of SPHK1 and phosphorylation level of Akt in NSCLC cell, but showed on significant effects on Akt expression. Treatment with SPHK1 inhibitor and Akt reduced the effects of HULC overexpression on proliferation and apoptosis of NSCLC cells. But the treatment showed no significant effects on HULC expression. SPHK1 inhibitor treatment inhibited phosphorylation of Akt, while Akt inhibitor treatment showed no significant effects on SPHK1 expression. CONCLUSIONS: LncRNA HULC overexpression can promote NSCLC cell proliferation and inhibit cell apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and further induce the activation of its downstream PI3K/Akt pathway.

High expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in glioma.

Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.

Long noncoding RNA HULC regulates the NF‐κB pathway and represents a promising prognostic biomarker in liver cancer

Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis

The Significance of Long Non-coding RNA HULC in Predicting Prognosis and Metastasis of Cancers: a Meta-Analysis

LncRNA HULC Promotes Non-Small Cell Lung Cancer Cell Proliferation and Inhibits the Apoptosis by Up-Regulating Sphingosine Kinase 1 (SPHK1) and Its Downstream PI3K/Akt Pathway

HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas

Expression and clinical significance of long non-coding RNA HULC in colorectal cancer tissues

Expression and Prognostic Value of LncRNA HULC in Colorectal Cancer

LncRNA PTCSC3 and Lncrna HULC Negatively Affect Each Other to Regulate Cancer Cell Invasion and Migration in Gastric Cancer

Long Noncoding RNA Highly Up-regulated in Liver Cancer Predicts Unfavorable Outcome and Regulates Metastasis by MMPs in Triple-negative Breast Cancer

The Lncrna HULC Functions As an Oncogene by Targeting ATG7 and ITGB1 in Epithelial Ovarian Carcinoma

The Value of Lncrna NEAT1 As a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis

Long Non‐coding RNA HULC Stimulates the Epithelial–mesenchymal Transition Process and Vasculogenic Mimicry in Human Glioblastoma

Long Noncoding RNA HULC Promotes Colorectal Carcinoma Progression Through Epigenetically Repressing NKD2 Expression

The Long Noncoding RNA HULC Promotes Liver Cancer by Increasing the Expression of the HMGA2 Oncogene Via Sequestration of the Microrna-186.

HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus

Expression Levels of Lncrnas Are Prognostic for Hepatocellular Carcinoma Overall Survival.

Alncrna Hulc As An Effective Biomarker For Surveillance Of The Outcome Of Cancer: A Meta-Analysis

LncRNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of ERK and YB-1 to enhance hepatocarcinogenesis.

Long Non-Coding Rna Hulc As A Novel Serum Biomarker For Diagnosis And Prognosis Prediction Of Gastric Cancer